F. Hoffmann-La Roche Ltd., Biogen Idec and Merck to lead the market for Global Biobetters Market from 2018 to 2023

The report published by Knowledge Sourcing Intelligence titled “Global Biobetters Market - Forecast From 2018 to 2023” studies the various factors affecting the market for antibody drug conjugates. The report has been segmented by Type (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Others), Application (Oncology, Neurology, Nephrology, Orphan Indications, Others), and End-User (Biopharmaceuticals, Research Organizations).

In addition, the market for a biobetters has been estimated based on the geography, covering five regions namely North America, South America, Europe, Middle East, and Africa and the Asia Pacific, and some of the major economies in each of these regions. The market is expected to show modest growth during the forecast period due to major manufacturers investing in the development of the biobetters in the face of impending biosimilar competition. The low development cost of biobetters as compared to the reference biologics will also augment the market growth during the given forecast period. However, lack of awareness among the patient population in regards to the biobetters will restrain the growth of the biobetter market during the given forecast period.

Request Sample: www.knowledge-sourcing.com/requestsample&sample_id=1930

By type, monoclonal antibodies are projected to show significant market growth in the global biobetters market from 2018-2023.

It is estimated that the monoclonal antibodies will show robust growth during the forecast period and owing to the rising investment by the major players for the research and development of the monoclonal antibodies as biobetters. Patent expiration of the major blockbuster monoclonal antibody drugs will also drive the market during the given forecast period.

The North America region is estimated to dominate the market throughout the forecast period.

The demand for biobetters was comparatively high in the North America region owing to the presence of a number of key players in the region with a rising number of R&D activities. Asia-Pacific is expected to grow at a robust CAGR. The growth is fuelled by the increasing awareness of healthcare professionals and developing healthcare infrastructure in the region.

This report also includes a study of strategies and product portfolios of some of the leading companies in the global biobetter market. It consists of company profiles of the leading companies such as F. Hoffmann-La Roche Ltd, Amgen, and Celltrion among others.

Request customization or place an order: www.knowledge-sourcing.com/global-pbiobetters-market

About Us:
Knowledge Sourcing Intelligence (KSI) is a market research and consulting organization based out of India. KSI publishes research studies spanning across ten industry verticals. KSI has a team of experienced and young professionals with a singular focus on delivering high-quality research services to enterprises, non-government organizations, government agencies, and research institutes and organizations. We publish hundreds of reports per year centering on niche and latest technologies. We engage with key decision makers and stakeholders across the value chain to provide clients with a detailed analysis and bird’s-eye view of the market with whole market dynamics, statistical forecasts, competitive analysis, key trends, market drivers and challenges and strategic recommendations for making informed decisions. Our success lies in the effort of our analysts who strive to meet client expectations by delivering quality work within the stipulated deadlines.

Contact:
Knowledge Sourcing Intelligence LLP
2nd Floor, D-77, Sector 63
Noida, U.P. - 201301
India
E: sales@knowledge-sourcing.com | P: +1-866-714-4587

This release was published on openPR.